ALRPRB.PFD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALRPRB.PFD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alere has the GF Value Rank of 0.
The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.
GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).
We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.
After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of Alere's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
John Bridgen | officer: Sr VP, Business Development | 51 SAWYER ROAD, C/O INVERNESS MEDICAL INNOVATIONS INC, WALTHAM MA 02453 |
Geoffrey S Ginsburg | director | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Renuka Uppaluri | officer: Senior VP, Global R&D | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Mark Gladwell | officer: Senior VP, Global Operations | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Gregg J Powers | director | C/O QUANTUM CORPORATION, 224 AIRPORT PARKWAY SUITE 300, SAN JOSE CA 95110 |
Jonathan Wygant | officer: VP, Controller, CAO | 3750 TORREY VIEW COURT, SAN DIEGO X1 92130 |
Thomas Mckillop | director | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Melissa Guerdan | officer: SVP, Global Quality & Reg. | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Daniella Cramp | officer: Global Pres., Cardiometabolic | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
Sanjay Malkani | officer: Global Pres., Toxicology | 51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453 |
James Jr. Roosevelt | director | 51 SAWYER ROAD, SUITE 200, HOPKINTON MA 02453 |
Robert Bernard Hargadon | officer: SVP, Global Human Resources | 4327 LAKE WASHINGTON BLVD NE #6208, KIRKLAND WA 98033 |
John F Levy | director | C/O INNVERNESS MEDICAL INNOVATIONS, INC., 51 SAWYER ROAD, WALTHAM MA 02453 |
John Quelch | director | C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYER RD, WALTHAM MA 02453 |
Carol R Goldberg | director | C/O INVERNESS MEDICAL INNOVATIONS INC, 51 SAWYERS RD, WALTHAM MA 02453 |
From GuruFocus
By Canadian Value Canadian Value • 01-23-2014
By gurufocus gurufocus • 11-16-2010
By Vatalyst.com Vatalyst.com • 02-28-2012
By Alberto Abaterusso Alberto Abaterusso • 07-10-2017
By Holly LaFon Holly LaFon • 11-14-2017
By Vera Yuan Vera Yuan • 11-21-2014
By Tiziano Frateschi Tiziano Frateschi • 02-26-2018
By Vera Yuan Vera Yuan • 11-21-2014
By Alberto Abaterusso Alberto Abaterusso • 10-23-2016
By guruek guruek • 11-25-2010
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.